Antoine Bibaud-De Serres
Biographic Data
| ID | 7972570 |
|---|---|
| NAME | Antoine Bibaud-De Serres |
| GIVEN NAMES | Antoine Bibaud |
| FAMILY NAME | De Serres |
| SIGNATURE | DE SERRES A B |
| AFFILIATIONS | Université de Montréal |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy
Psilocybin has reemerged as a promising treatment for difficult-to-treat depression (DTD). Although there is limited evidence regarding interactions between psilocybin and other psychotropic drugs, clinical trials require that patients discontinue their antidepressants before study entry to isolate the benefits of psilocybin and to minimize the risk of adverse events. We present the first case of an adult patient with DTD who received psilocybin-…
No prominent works on this page.
Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy
Psilocybin has reemerged as a promising treatment for difficult-to-treat depression (DTD). Although there is limited evidence regarding interactions between psilocybin and other psychotropic drugs, clinical trials require that patients discontinue their antidepressants before study entry to isolate the benefits of psilocybin and to minimize the risk of adverse events. We present the first case of an adult patient with DTD who received psilocybin-…
Adverse effect (1 work) · Alternative medicine (1 work) · Antidepressant (1 work) · Anxiety (1 work) · Chemical synthesis and alkaloids (1 work) · Discontinuation (1 work) · Duloxetine (1 work) · Hallucinogen (1 work) · Internal Medicine (1 work) · Major depressive disorder (1 work)